Thalys(SH:603716) Xin Lang Cai Jing·2025-12-23 01:55Core Viewpoint - The stock of Sely Medical has experienced significant fluctuations, with a year-to-date increase of 200.97%, but a recent decline in the last 60 days by 22.70% [1] Group 1: Stock Performance - As of December 23, Sely Medical's stock price is 21.73 CNY per share, with a market capitalization of 4.567 billion CNY [1] - The stock has seen a net inflow of 9.61586 million CNY from major funds, with large orders accounting for 7.11% of total buy and 10.93% of total sell [1] - The stock has appeared on the daily trading leaderboard 37 times this year, with the most recent net buy of 146 million CNY on August 26 [1] Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a year-on-year decrease of 39.64%, and a net profit loss of 87.2441 million CNY, down 55.72% [2] - The company has not distributed any dividends in the last three years, with a total payout of 27.0741 million CNY since its A-share listing [3] Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22%, while the average number of circulating shares per person increased by 12.64% to 2,986 shares [2] - Notable institutional shareholders include Caixin Advantage Industry Rotation Mixed Fund and Guangfa Healthcare Stock A, with significant increases in holdings [3]